Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 908 results for "astrazeneca"

FDA approves Teva's generic AstraZeneca heartburn drug

Update: Teva Set To Launch Generic Nexium, Outlook Positive

Summary Teva announced Monday FDA approval for its generic version of AstraZeneca's $3-billion-a-year seller Nexium. Teva stands to generate significant revenues from generic Nexium. The company should see an earnings boost following the upcoming ... Seeking Alpha, 14 hours ago
FDA Clears First Generic Esomeprazole for GERD Dermatology Online Journal, 1 day ago

59 images for astrazeneca, 8 hours ago
Business Cloud News, 12 hours ago
American Banking News - Forex, 3 days ago
One News Page United Kingdom, 11 hours ago
Clinton Global Initiative, 1 day ago
Digital Look, 5 days ago
One News Page United Kingdom, 3 days ago
Pharmaceutical Business Review, 4 days ago
Pharma Letter, 5 days ago
Scottish Daily Express, 5 days ago

AstraZeneca Set to Possibly Pullback After Yesterday's Rally of 1.87%

AstraZeneca (NYSE:AZN) traded in a range yesterday that spanned from a low of $71.26 to a high of $72.22. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $71.36 on volume of 4.8 million shares. Often times ...
 Individual.com6 hours ago Look for Shares of AstraZeneca to Potentially Pullback after Yesterday's 1.87% Rise  Individual.com6 hours ago
Business Standard India

Ranbaxy suffers fresh jolt

The US Food and Drug Administration has revoked Ranbaxy's 180-day exclusivity right to sell the generic version of AstraZeneca's blockbuster heartburn (acidity) drug Nexium.
 The Telegraph6 hours ago Ranbaxy loses 180-day exclusivity on generic version of AstraZeneca's Nexium  VC Circle20 hours ago Ranbaxy loses generic exclusivity over $6 billion Nexium market  DNA3 hours ago Cipla to gain from Teva's exclusivity on Nexium  Livemint.com8 hours ago
Business Cloud News

Box Inc (BOX) To Provide AstraZeneca (AZN) With Cloud Services

UK-based biopharmaceutical giant, AstraZeneca plc (ADR) ( NYSE:AZN ) has reportedly entered into a deal with Box Inc ( NYSE:BOX ). As a part of the deal Box will be providing cloud and collaboration services to AstraZeneca's 51,000 workforce ...
 Bidness Etc8 hours ago Pfizer, Inc. Should Forget AstraZeneca and Buy This Company Instead  Motley Fool15 hours ago AstraZeneca taps Box amidst IT refresh  Business Cloud News13 hours ago AstraZeneca consolidates on-site IT to sole service provider Computacenter  Computer Weekly17 hours ago

AstraZeneca embraces Box cloud services for 51,000 workers

Box will provide 51,000 employees at pharmaceutical giant AstraZeneca with access to its cloud storage and collaboration platform to enable teams from 100 countries to work together. AstraZeneca said that it needed staff to work across the ... hours ago Box signs up 51,000 AstraZeneca users  Cloud Computing Intelligence11 hours ago

AstraZeneca (AZN) Trading Near $71.32 Resistance Level

The patented option-trade picking algorithms that power's Artificial Intelligence Center are highlighting two trades on AstraZeneca Plc ("AZN) today after it closed at ...
 Individual.com13 hours ago Potential AstraZeneca (AZN) Trade Has 3.40% Downside Protection  Individual.com4 days ago Potential AstraZeneca (AZN) Trade Targets 3.02% Return  Individual.com1 week ago Potential AstraZeneca (AZN) Trade Could Hit 2.22% Return  Individual.com6 days ago

Persomics Chooses AstraZeneca BioHub in Waltham, Massachusetts for USA...

Persomics USA Inc., a leading biotechnology company with innovative solutions that miniaturize, accelerate and increase the scale of functional genomics and phenotypic screening, has decided to establish its world-class laboratory and US ...
 PRWeb17 hours ago Persomics Secures a First Round of Funding and Opens USA Operations  PRWeb12 hours ago

Shares of AstraZeneca Exhibit Possible Trend Reversal as it Trades Higher (AZN)

AstraZeneca shares are trading on heavy volume today, having risen 1.7% to $71.75. Approximately 2.0 million shares have changed hands today vs. average 30-day volume of 1.7 million shares. Spikes in volume can validate a breakout or signify a ...
 Individual.com12 hours ago
Yahoo! UK and Ireland

AstraZeneca plc Could Be Back To Growth By 2016

When Pascal Soriot took over as the new boss of AstraZeneca (LSE: AZN) (NYSE: AZN.US) in October 2012, his brief was to get the pharmaceuticals giant back to earnings growth as soon as possible. With patents on a number of key drugs set to expire ...
 Yahoo! UK and Ireland13 hours ago

Eli Lilly And Company And AstraZeneca Initiate Pivotal Clinical Trial For Patients With Early Alzheimer's Disease

INDIANAPOLIS, Dec. 1, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced enrollment of the first patient into AMARANTH, a Phase II/III study of an oral beta secretase cleaving enzyme (BACE) inhibitor currently in ...
 Drugs.com19 hours ago AstraZeneca and Eli Lilly start critical clinical trial for Alzheimer's drugs  Business Standard1 month ago AstraZeneca and Lilly move Alzheimer's drug into big trial  Reuters1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less